Cholesterol Coronary Artery Disease Heart attacks 
Dr. Paddy Barrett
DECEMBER 19, 2023
Reversing or regressing coronary artery disease is possible. You cannot eliminate the plaque entirely, but multiple clinical trials have shown plaque regression using high-intensity cholesterol-lowering treatments, which I have discussed previously. All of these components influence the risk of future heart attacks.
Dr. Paddy Barrett
SEPTEMBER 20, 2024
The fundamental cause of atherosclerosis is when a cholesterol particle crosses into the artery wall from the bloodstream, gets stuck, and sets off an inflammatory process 1. ApoB particles crossing the artery wall to cause Atherosclerosis. Every cholesterol particle has a protein marker called ApoB on its outside.
Dr. Paddy Barrett
FEBRUARY 27, 2024
When you look at the risk of having a heart attack, it is true that the older you are, the greater the odds of having a heart attack 1. While only 1-2% of those having a heart attack are less than 65 years of age, 1-2% of this very large number means a LOT of heart attacks. So far, so good.
Dr. Paddy Barrett
JUNE 21, 2024
Some groups will state that any heart events at less than 55 years of age for males and less than 65 for females define early heart disease. A heart attack in a 56-year-old male is early in anyone's books. However, the above age cut-offs give a good idea of what we consider the early presentation of heart disease.
DAIC
APRIL 11, 2024
These new findings suggest that people with high-risk plaques that are likely to rupture could benefit from the procedure as a pre-emptive measure rather than waiting for a heart attack or other severe reduction in blood flow to occur. During PCI, an operator inserts a stent into a blocked artery through a catheter in the groin or arm.
DAIC
JANUARY 23, 2024
Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3
DAIC
JANUARY 25, 2024
mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease.
Expert insights. Personalized for you.
105 
Let's personalize your content